APOC1


Summary: This gene encodes a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. The encoded protein plays a central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism. This protein has also been shown to inhibit cholesteryl ester transfer protein in plasma. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Sep 2016].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
apolipoprotein C1MIM:107710Ensembl:ENSG00000130208HGNC:HGNC:607PA5119q13.32

GO terms in APOC1


Term TypeEvidence TypeGO Term IDGO Des.
BPTASGO:0006629lipid metabolic process
BPIEAGO:0006641triglyceride metabolic process
BPIEAGO:0008203cholesterol metabolic process
BPTASGO:0010873positive regulation of cholesterol esterification
BPIDAGO:0010900negative regulation of phosphatidylcholine catabolic process
BPIDAGO:0010916negative regulation of very-low-density lipoprotein particle clearance
BPICGO:0032374regulation of cholesterol transport
BPIDAGO:0032375negative regulation of cholesterol transport
BPIDAGO:0033344cholesterol efflux
BPIDAGO:0033700phospholipid efflux
BPIDAGO:0034369plasma lipoprotein particle remodeling
BPTASGO:0034375high-density lipoprotein particle remodeling
BPTASGO:0034379very-low-density lipoprotein particle assembly
BPIDAGO:0034382chylomicron remnant clearance
BPIGIGO:0034447very-low-density lipoprotein particle clearance
BPTASGO:0034447very-low-density lipoprotein particle clearance
BPIEAGO:0042157lipoprotein metabolic process
BPIEAGO:0043085positive regulation of catalytic activity
BPIDAGO:0045717negative regulation of fatty acid biosynthetic process
BPIDAGO:0045833negative regulation of lipid metabolic process
BPIDAGO:0048261negative regulation of receptor-mediated endocytosis
BPIDAGO:0050995negative regulation of lipid catabolic process
BPIDAGO:0051005negative regulation of lipoprotein lipase activity
CCTASGO:0005576extracellular region
CCIDAGO:0005783endoplasmic reticulum
CCIDAGO:0034361very-low-density lipoprotein particle
CCIDAGO:0034364high-density lipoprotein particle
CCTASGO:0042627chylomicron
MFIDAGO:0004859phospholipase inhibitor activity
MFIDAGO:0005504fatty acid binding
MFTASGO:0031210phosphatidylcholine binding
MFIDAGO:0055102lipase inhibitor activity
MFTASGO:0060228phosphatidylcholine-sterol O-acyltransferase activator activity

Gene expression in normal tissue: APOC1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in APOC1


DatabasePathway IDPathway Des.
kegghsa04979Cholesterol metabolism - Homo sapiens (human)
pharmgkbPA2031Statin Pathway, Pharmacodynamics
wikipathwaysWP430Statin Pathway
reactomeR-HSA-174824Plasma lipoprotein assembly, remodeling, and clearance
reactomeR-HSA-174824Plasma lipoprotein assembly, remodeling, and clearance
reactomeR-HSA-382551Transport of small molecules
reactomeR-HSA-382551Transport of small molecules
reactomeR-HSA-8866423VLDL assembly
reactomeR-HSA-8963898Plasma lipoprotein assembly
reactomeR-HSA-8964043Plasma lipoprotein clearance
reactomeR-HSA-8964043Plasma lipoprotein clearance
reactomeR-HSA-8964046VLDL clearance
reactomeR-HSA-8964046VLDL clearance

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD353PD03259013

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in APOC1

​​​​